FDA - Gridwave

Life Gridwave

FDA's Criteria for 'Breakthrough' Devices: An Analysis of AI-Powered Innovations

Editorial Staff 5 days ago

Life Gridwave

Trump Administration's Proposed 100% Tariff on Patented Medicines

Editorial Staff 5 days ago

Politics Gridwave

FDA Approves Foundayo: A New Daily Pill for Obesity Management

Editorial Staff 6 days ago

Life Gridwave

FDA's Advisory Committee Conflict of Interest Guidance Needs Urgent Finalization

Editorial Staff 6 days ago

Life Gridwave

FDA Reconsiders Injectable Peptide Compounding Regulations

Editorial Staff 6 days ago

Life Gridwave

FDA Approval of Denali Medicine for Hunter Syndrome: Implications for Rare Disease Drug Development

Editorial Staff 12 days ago

Life Gridwave

FDA Approval of Denali Therapeutics Drug Enhances Rare Disease Treatment Landscape

Editorial Staff 13 days ago

Life Gridwave

Former FDA Commissioner Highlights Political Pressures Impacting Agency's Role

Editorial Staff 19 days ago

Money Gridwave

GE HealthCare Secures FDA 510(k) Clearance for New Product

Editorial Staff 24 days ago

Life Gridwave

FDA Scrutinizes Telehealth Marketing of GLP-1 Drugs

Editorial Staff 26 days ago

Life Gridwave

FDA Grants Leucovorin Approval for Rare Disorder Without Traditional Trial Data

Editorial Staff 27 days ago

Life Gridwave

FDA Issues Warning to Novo Nordisk Amid Lilly's Strategic Expansion in China

Editorial Staff 27 days ago

Life Gridwave

Sen. Johnson Questions FDA's Drug Approval Process for Rare Diseases

Editorial Staff 28 days ago

Life Gridwave

FDA Issues Third Warning to Novo Nordisk Over GLP-1 Drug Reporting Failures

Editorial Staff 28 days ago

Money Gridwave

FDA Approves Leucovorin for Rare Genetic Disorder, Implications for Treatment Framework

Editorial Staff 28 days ago

Life Gridwave

Senator Investigates FDA as BioNTech Founders Depart for New Venture

Editorial Staff 28 days ago

Life Gridwave

FDA Approves Over-the-Counter Availability of Opill Contraceptive

Editorial Staff 28 days ago

Life Gridwave

Concerns Arise Over FDA's Reduced Use of Advisory Committees

Editorial Staff 29 days ago

Money Gridwave

FDA's Controversial Actions Against UniQure Raise Political Concerns

Editorial Staff about 1 month ago

Money Gridwave

FDA-UniQure Tussle and Pfizer's Obesity Drug Approval in China

Editorial Staff about 1 month ago

#FDA

FDA Meeting Delay Impacts Biotech Operations

FDA Delay Impacts Biotech Operations, Leading to Closure

FDA Clearance Granted to GE HealthCare's Photonova Spectra CT System

FDA's Criteria for 'Breakthrough' Devices: An Analysis of AI-Powered Innovations

Trump Administration's Proposed 100% Tariff on Patented Medicines

FDA Approves Foundayo: A New Daily Pill for Obesity Management

FDA's Advisory Committee Conflict of Interest Guidance Needs Urgent Finalization

FDA Reconsiders Injectable Peptide Compounding Regulations

FDA Approval of Denali Medicine for Hunter Syndrome: Implications for Rare Disease Drug Development

FDA Approval of Denali Therapeutics Drug Enhances Rare Disease Treatment Landscape

Former FDA Commissioner Highlights Political Pressures Impacting Agency's Role

GE HealthCare Secures FDA 510(k) Clearance for New Product

FDA Scrutinizes Telehealth Marketing of GLP-1 Drugs

FDA Grants Leucovorin Approval for Rare Disorder Without Traditional Trial Data

FDA Issues Warning to Novo Nordisk Amid Lilly's Strategic Expansion in China

Sen. Johnson Questions FDA's Drug Approval Process for Rare Diseases

FDA Issues Third Warning to Novo Nordisk Over GLP-1 Drug Reporting Failures

FDA Approves Leucovorin for Rare Genetic Disorder, Implications for Treatment Framework

Senator Investigates FDA as BioNTech Founders Depart for New Venture

FDA Approves Over-the-Counter Availability of Opill Contraceptive

Concerns Arise Over FDA's Reduced Use of Advisory Committees

FDA's Controversial Actions Against UniQure Raise Political Concerns

FDA-UniQure Tussle and Pfizer's Obesity Drug Approval in China